CURE’s small lymphocytic lymphoma (SLL) page is a go-to resource for oncology news and updates in the world of SLL. Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in small lymphocytic lymphoma (SLL).
November 21st 2019
In partnership with the Australian Therapeutic Goods Administration (TGA) and Health Canada, the Food and Drug Administration (FDA) has granted supplemental approval to Calquence (acalabrutinib) for the treatment of adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
May 15th 2019
The Food and Drug Administration has approved the combination use of Venclexta plus Gazyva for the frontline treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
November 29th 2018
Take a look at the FDA’s decisions for the treatment of SLL that happened this year.
November 12th 2018
Imbruvica (ibrutinib) is a safe treatment for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell lymphoma (MCL), according to a pooled analysis of four clinical trials.